Silverfin false false 31/12/2025 01/01/2025 31/12/2025 Dr B Miller 02/09/2025 06/04/2017 Dr S B Primrose 30/11/2025 04/04/2025 Mr A Rossignol 29/12/2021 Ms R Singh 23/12/2024 Dr M J Tomecka 31/05/2026 06/04/2017 01 September 2026 The principal activity of the Company during the financial period continued to be the development of novel microfluidic devices to be used in industrial processes. SC562625 2025-12-31 SC562625 bus:Director1 2025-12-31 SC562625 bus:Director2 2025-12-31 SC562625 bus:Director3 2025-12-31 SC562625 bus:Director4 2025-12-31 SC562625 bus:Director5 2025-12-31 SC562625 2024-12-31 SC562625 core:CurrentFinancialInstruments 2025-12-31 SC562625 core:CurrentFinancialInstruments 2024-12-31 SC562625 core:ShareCapital 2025-12-31 SC562625 core:ShareCapital 2024-12-31 SC562625 core:SharePremium 2025-12-31 SC562625 core:SharePremium 2024-12-31 SC562625 core:OtherCapitalReserve 2025-12-31 SC562625 core:OtherCapitalReserve 2024-12-31 SC562625 core:RetainedEarningsAccumulatedLosses 2025-12-31 SC562625 core:RetainedEarningsAccumulatedLosses 2024-12-31 SC562625 core:PlantMachinery 2024-12-31 SC562625 core:ComputerEquipment 2024-12-31 SC562625 core:PlantMachinery 2025-12-31 SC562625 core:ComputerEquipment 2025-12-31 SC562625 core:CostValuation 2024-12-31 SC562625 core:CostValuation 2025-12-31 SC562625 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2025-12-31 SC562625 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2024-12-31 SC562625 bus:OrdinaryShareClass1 2025-12-31 SC562625 bus:OrdinaryShareClass2 2025-12-31 SC562625 bus:OrdinaryShareClass3 2025-12-31 SC562625 2025-01-01 2025-12-31 SC562625 bus:FilletedAccounts 2025-01-01 2025-12-31 SC562625 bus:SmallEntities 2025-01-01 2025-12-31 SC562625 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 SC562625 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 SC562625 bus:Director1 2025-01-01 2025-12-31 SC562625 bus:Director2 2025-01-01 2025-12-31 SC562625 bus:Director3 2025-01-01 2025-12-31 SC562625 bus:Director4 2025-01-01 2025-12-31 SC562625 bus:Director5 2025-01-01 2025-12-31 SC562625 core:PlantMachinery core:TopRangeValue 2025-01-01 2025-12-31 SC562625 core:ComputerEquipment core:TopRangeValue 2025-01-01 2025-12-31 SC562625 2024-01-01 2024-12-31 SC562625 core:CurrentFinancialInstruments 2025-01-01 2025-12-31 SC562625 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 SC562625 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 SC562625 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 SC562625 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 SC562625 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 SC562625 bus:OrdinaryShareClass3 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC562625 (Scotland)

UFRACTION8 LIMITED

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH THE REGISTRAR

UFRACTION8 LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025

Contents

UFRACTION8 LIMITED

BALANCE SHEET

AS AT 31 DECEMBER 2025
UFRACTION8 LIMITED

BALANCE SHEET (continued)

AS AT 31 DECEMBER 2025
Note 2025 2024
£ £
Fixed assets
Investments 4 573,023 573,023
573,023 573,023
Current assets
Debtors 5 260,974 49,414
Cash at bank and in hand 1,172,287 1,701,058
1,433,261 1,750,472
Creditors: amounts falling due within one year 6 ( 6,298) ( 61,825)
Net current assets 1,426,963 1,688,647
Total assets less current liabilities 1,999,986 2,261,670
Net assets 1,999,986 2,261,670
Capital and reserves
Called-up share capital 7 194 216
Share premium account 2,798,856 2,804,858
Other reserves 22 0
Profit and loss account ( 799,086 ) ( 543,404 )
Total shareholders' funds 1,999,986 2,261,670

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Ufraction8 Limited (registered number: SC562625) were approved and authorised for issue by the Board of Directors on 01 September 2026. They were signed on its behalf by:

Mr A Rossignol
Director
UFRACTION8 LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
UFRACTION8 LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Ufraction8 Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is Suite 1/14 45 Vicar Street, Falkirk, FK1 1LL, Scotland, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors are actively engaged in fundraising discussions with existing and prospective investors and, having regard to the Company’s record of successfully raising equity finance, most recently in 2024, they have a reasonable expectation that sufficient funding will be secured within the required timeframe. In the interim, the directors have implemented measures to reduce the Company’s cash outflows while preserving the development activities necessary to support a successful fundraise.

Notwithstanding the above, there can be no certainty that the fundraising will complete or complete on a timely basis. These conditions indicate the existence of a material uncertainty which may cast significant doubt over the Company’s ability to continue as a going concern and, therefore, its ability to realise its assets and discharge its liabilities in the normal course of business.

The financial statements do not include the adjustments that would result if the Company were unable to continue as a going concern.

After due consideration of these matters, the directors continue to adopt the going concern basis in preparing the financial statements

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.

Tangible fixed assets

Tangible fixed assets are stated at cost, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost of each asset on a straight-line basis over its expected useful life, as follows:

Plant and machinery 5 years straight line
Computer equipment 3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account. No impairments were noted in the period.

Fixed asset investments

Interest in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors and bank loans that are classified as debt, are initially recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 4 2

3. Tangible assets

Plant and machinery Computer equipment Total
£ £ £
Cost
At 01 January 2025 1,581 4,096 5,677
At 31 December 2025 1,581 4,096 5,677
Accumulated depreciation
At 01 January 2025 1,581 4,096 5,677
At 31 December 2025 1,581 4,096 5,677
Net book value
At 31 December 2025 0 0 0
At 31 December 2024 0 0 0

4. Fixed asset investments

Investments in subsidiaries

2025
£
Cost
At 01 January 2025 573,023
At 31 December 2025 573,023
Carrying value at 31 December 2025 573,023
Carrying value at 31 December 2024 573,023

5. Debtors

2025 2024
£ £
Amounts owed by own subsidiaries 251,086 20,766
Corporation tax 0 14,770
Other debtors 9,888 13,878
260,974 49,414

6. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 222 2,242
Other taxation and social security 0 6,174
Other creditors 6,076 53,409
6,298 61,825

There are no amounts included above in respect of which any security has been given by the company.

7. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
1,009,309 Ordinary shares of £ 0.0001 each (2024: 1,233,200 shares of £ 0.0001 each) 101 123
346,540 Seed ordinary shares of £ 0.0001 each (2024: 34,654 shares of £ 0.001 each) 35 35
583,310 A ordinary shares of £ 0.0001 each 58 58
194 216

On 3rd September 2025 the company converted 223,891 ordinary £0.0001 shares into 223,891 deferred shares of £0.0001. The company then carried out a purchase and cancellation of these shares for a consideration of £0.01.

8. Related party transactions

Transactions with entities in which the entity itself has a participating interest

2025 2024
£ £
Amounts owed by own subsidiary 251,086 20,766

The above loans are advanced to a subsidiary company in order to conduct R&D activities. While this loan is unsecured, repayable 18 months after notice of demand raised and subject to interest at Bank of England base rate, this will only be possible when commercial activities commence in the subsidiary.